LGALS1 and depressive symptom measurement: This rather marked switch in the action of Gal (1–15) from inducing depression into antidepressant activity when coactivated with the 5-HT1A receptor agonist may be related to the Gal (1–15)-induced increases in the Bmax values of 5-HT1A high-affinity agonist binding sites.